omega-n-methylarginine has been researched along with dehydroepiandrosterone in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (dehydroepiandrosterone) | Trials (dehydroepiandrosterone) | Recent Studies (post-2010) (dehydroepiandrosterone) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 10,043 | 639 | 1,826 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Green, K; Guo, L; Stanton, RC; Zhang, Z | 1 |
1 other study(ies) available for omega-n-methylarginine and dehydroepiandrosterone
| Article | Year |
|---|---|
Suppression of interleukin-1 beta-induced nitric oxide production in RINm5F cells by inhibition of glucose-6-phosphate dehydrogenase.
Topics: Animals; Cells, Cultured; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Glucosephosphate Dehydrogenase; Interleukin-1; Malate Dehydrogenase; Male; NADP; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oligonucleotides, Antisense; omega-N-Methylarginine; Protein Transport; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Time Factors; Transfection; Tumor Cells, Cultured | 2002 |